Arm Holdings closed Monday down 9.71%, at roughly $240 a share — TradingKey has the percentage, Benzinga had it at $240.40 intraday. Nothing happened at Arm. What happened was a weekend essay.

Anthropic CEO Dario Amodei argued on Saturday that AI companies should slow the pace at which they improve their most powerful models, with Sam Altman and Elon Musk broadly agreeing, per The Motley Fool. Chip stocks took it as a threat to the AI build-out.

The interesting part is how unevenly it landed. Same headline, same session, per TradingKey: Nvidia −3.47%, Micron −6.30%, Arm −9.71%. Arm fell nearly three times as hard as the company that actually sells the AI chips — see the rest of Monday's board.

Why Arm wore the worst of it

Price. Benzinga puts Arm near 270x trailing earnings — on $4.92bn of revenue and $904m of net profit (TradingKey). At that multiple almost none of the share price is this year's profit; it's the out-years. Piper Sandler's Sept 9 Overweight note is the cleanest version of that case: IP revenue compounding about 20% a year to roughly $12bn by fiscal 2031, and earnings doubling if Arm takes around 10% of the ASIC market.

Every one of those figures assumes the build-out keeps its current pace. And the two businesses are wired differently. Nvidia gets paid when a GPU ships this quarter. Arm gets a royalty when chips its licensees designed years ago finally ship in volume, plus licence fees for designs that ship later still. So "slow the roadmap" hits Arm's 2030 line long before it touches anyone's 2026 revenue — and 2030 is where the whole 270x multiple is parked. That's the asymmetry.

The ripple: Marvell dropped about 7% in Monday's premarket (Yahoo Finance) on the same wiring. Marvell books design and engineering revenue on the custom hyperscaler ASICs that Arm licenses cores into. If one of those silicon programmes slips a quarter, Marvell loses the design fee now and Arm loses the royalty that would have followed it — one delay, two P&Ls, years apart.

What would flip it: a real number, not a mood. Arm traded as high as $452.70 earlier this year (Invezz). Watch the next round of hyperscaler capex guides: if those budgets still support roughly 20% IP growth, Monday was a de-rating of sentiment, not demand. Invezz separately notes the FTC is reviewing Arm's licensing practices — a review in progress, with no findings announced.

As of 14:39 IST / 05:09 ET, Sep 15, 2026. Sources: Benzinga, TradingKey, Invezz, The Motley Fool, Yahoo Finance. For discussion and education only — not investment advice. Verify before acting.